ES2014445B3 - Composiciones farmaceuticas que contienen compuestos 5-fenil-1,3-dioxialquenilicos. - Google Patents

Composiciones farmaceuticas que contienen compuestos 5-fenil-1,3-dioxialquenilicos.

Info

Publication number
ES2014445B3
ES2014445B3 ES87104456T ES87104456T ES2014445B3 ES 2014445 B3 ES2014445 B3 ES 2014445B3 ES 87104456 T ES87104456 T ES 87104456T ES 87104456 T ES87104456 T ES 87104456T ES 2014445 B3 ES2014445 B3 ES 2014445B3
Authority
ES
Spain
Prior art keywords
phenyl
compounds
pharmaceutical compositions
compositions containing
dioxialkenylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87104456T
Other languages
English (en)
Inventor
Richard August Mueller
Richard Allen Partis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of ES2014445B3 publication Critical patent/ES2014445B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/794Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
    • C07C49/796Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring polycyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/56Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/213Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C49/217Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/213Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C49/217Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • C07C49/223Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings polycyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES87104456T 1986-03-28 1987-03-26 Composiciones farmaceuticas que contienen compuestos 5-fenil-1,3-dioxialquenilicos. Expired - Lifetime ES2014445B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/845,309 US4649157A (en) 1986-03-28 1986-03-28 Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds

Publications (1)

Publication Number Publication Date
ES2014445B3 true ES2014445B3 (es) 1990-07-16

Family

ID=25294933

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87104456T Expired - Lifetime ES2014445B3 (es) 1986-03-28 1987-03-26 Composiciones farmaceuticas que contienen compuestos 5-fenil-1,3-dioxialquenilicos.

Country Status (10)

Country Link
US (1) US4649157A (es)
EP (1) EP0239105B1 (es)
JP (1) JPS62246535A (es)
AT (1) ATE53004T1 (es)
AU (1) AU599965B2 (es)
CA (2) CA1284651C (es)
DE (1) DE3762854D1 (es)
ES (1) ES2014445B3 (es)
GR (1) GR3000512T3 (es)
ZA (1) ZA872276B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940011244B1 (ko) * 1988-11-25 1994-12-03 다이닛뽕잉끼 가가꾸 고오교오 가부시끼가이샤 신장 질환 치료제
WO1993009774A1 (en) * 1991-11-18 1993-05-27 G.D. Searle & Co. 2-(4-substituted)phenylmethylene derivatives and methods of use
JPH06107588A (ja) * 1992-10-01 1994-04-19 Shiseido Co Ltd 1−スチリル−3−t−ブチル−1、3プロパンジオン誘導体及びそれを配合した皮膚外用剤
GB0613518D0 (en) * 2006-07-06 2006-08-16 Phytopharm Plc Chemical compounds
KR101563370B1 (ko) * 2007-01-08 2015-10-26 앤드로사이언스 코포레이션 (치환된 페닐)-프로페날 잔기를 갖는 화합물, 이의 유도체, 생물학적 활성, 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130661A (en) * 1973-11-15 1978-12-19 Merck & Co., Inc. Substituted benzoylacrylanilides
DE2850330A1 (de) * 1977-12-01 1979-06-07 Sandoz Ag Verfahren zur herstellung von phenylbutenonen
CA1125762A (en) * 1979-07-13 1982-06-15 Alexander E. Wick Dihydronicotinic acid derivatives and process for the preparation thereof
FR2481118A1 (fr) * 1980-04-24 1981-10-30 Roussel Uclaf Application a titre de medicaments de derives substitues de l'acide phenyl-4-oxo-2-butenoique
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
US4587260A (en) * 1984-06-21 1986-05-06 Warner-Lambert Company Dibenzalacetone and benzylcinnamate as non-steroidal anti-inflammatory compounds and compositions thereof
US4567279A (en) * 1984-12-13 1986-01-28 Usv Pharmaceutical Corp. Diarylhydroxy alkanones and alkenones antiallergy agents

Also Published As

Publication number Publication date
EP0239105B1 (en) 1990-05-23
EP0239105A2 (en) 1987-09-30
ZA872276B (en) 1988-05-25
AU599965B2 (en) 1990-08-02
ATE53004T1 (de) 1990-06-15
CA1303994C (en) 1992-06-23
GR3000512T3 (en) 1991-07-31
US4649157A (en) 1987-03-10
DE3762854D1 (de) 1990-06-28
EP0239105A3 (en) 1988-03-02
AU7066287A (en) 1987-10-01
CA1284651C (en) 1991-06-04
JPS62246535A (ja) 1987-10-27

Similar Documents

Publication Publication Date Title
PH23847A (en) Polypeptide
PT87820A (pt) Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi
TNSN87033A1 (fr) TOLUNITRILES SUBSTITUES PAR DESα - HETEROCYCLES
ES485540A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas, congrupos ester funcionalizados
KR870006891A (ko) 구강 위생 조성물
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
GB8727099D0 (en) Compositions containing melantonin/homologues
GR71207B (es)
ES2014445B3 (es) Composiciones farmaceuticas que contienen compuestos 5-fenil-1,3-dioxialquenilicos.
SE8405588D0 (sv) New compounds
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
FR2514765B1 (es)
ES2054011T3 (es) Un proceso para la preparacion de un compuesto, "leualacina".
DK89289A (da) Anvendelse af 1,4-dihydropyridin-derivater til fremstilling af laegemiddel til afvaenning af alkoholister
ATE118209T1 (de) Pyridin-3-percarboxylsäure monopersulfat.
DE3264543D1 (en) Cyclic sulfenamides, process for their preparation, medicines containing them and preparation of the latter
PT90483A (pt) Processo para a proteccao de produtos alimentares contra a oxidacao
BE893025A (fr) Derives de l'acide 1,4-thiazane-carboxilique leurs preparation et utilisation ainsi que les compositions contenant ces derives.
DE68922596D1 (de) 3-(3-Ethyl-1,2,4-oxadiazol-5-yl)-1-azabicycloheptan, Verfahren zu seiner Herstellung und dieses enthaltende pharmazeutische Zubereitungen.
DE3663141D1 (en) Thiochroman derivative, process for its preparation and pharmaceutical compositions containing it
ES2038799T3 (es) Derivados de 3-ciano-4-fenil-pirrol.
AU577570B2 (en) Mefloquine quinates
UA26982A1 (uk) Похідhі малоhової кислоти, які проявляють властивості іhгібітору росту рослиh
DE3469358D1 (en) Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments